Injectable Drug Delivery Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Injectable Drug Delivery Pipeline Market Report Overview

Injectable drug delivery devices are defined as the administration of a drug into a patient’s blood through a delivery device. The injectable drug delivery pipeline market research report provides a comprehensive understanding of the products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·       Sustained Release Injectable Systems

·       Needleless Systems

·       Liposomal System

Key Territories ·       The US

·       Europe

·       Israel

·       Japan

·       Canada

Key Regulatory Paths ·       510(k)

·       CE

·       Ninsho

·       TGA

·       UKCA

Leading Companies ·       AbbVie Inc

·       Activoris Medizintechnik GmbH

·       Actuated Medical Inc

·       Acumen Pharmaceuticals Inc

·       Adalvo Ltd

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Injectable Drug Delivery Pipeline Market by Segments

The key segments of the injectable drug delivery pipeline market are sustained release injectable systems, needleless systems, and liposomal systems. As of December 2024, sustained release injectable systems account for the highest share of pipeline products.

Injectable Drug Delivery Pipeline Market Analysis by Segments, 2024 (%)

Injectable Drug Delivery Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Injectable Drug Delivery Pipeline Market

Download a Free Report Sample

Injectable Drug Delivery Pipeline Market Segmentation by Territories

A few of the key territories with the injectable drug delivery pipeline market are the US, Europe, Israel, Japan, and Canada. As of December 2024, the US accounts for the highest number of pipeline products.

Injectable Drug Delivery Pipeline Market Analysis by Territories, 2024 (%)

Injectable Drug Delivery Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Injectable Drug Delivery Pipeline Market

Download a Free Report Sample

Injectable Drug Delivery Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the injectable drug delivery pipeline products market are 510(k), CE, Ninsho, TGA, and UKCA. As of December 2024, 510(k) is the most followed pathway for pipeline products in the injectable drug delivery market.

Injectable Drug Delivery Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Injectable Drug Delivery Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Injectable Drug Delivery Pipeline Market

Download a Free Report Sample

Injectable Drug Delivery Pipeline Market – Competitive Landscape

A few of the key companies associated with the injectable drug delivery pipeline market are AbbVie Inc, Activoris Medizintechnik GmbH, Actuated Medical Inc., Acumen Pharmaceuticals Inc., and Adalvo Ltd, among others.

AbbVie Inc: It is a specialty biopharmaceutical company headquartered in North Chicago, Illinois, the US. The company discovers, develops, manufactures, and commercializes drugs for the treatment of chronic and complex diseases. Its drugs are indicated for the treatment of metabolic and rheumatological diseases, neurological disorders, skin diseases, rheumatoid arthritis, pain related to endometriosis, pediatric Crohn’s disease, cancer, and other serious health conditions.

Actuated Medical Inc.: It is a medical device company that develops minimally invasive instruments. The company’s products include a tube clear system, a device designed to clear sluggish and clogged indwelling feeding tubes, and the grip tract-gi endoscopic tissue manipulator, a tool that enhances endoscopic visualization through dynamic tissue manipulation. It operates through a manufacturing facility in Bellefonte. Actuated Medical is headquartered in Bellefonte, Pennsylvania, the US.

Injectable Drug Delivery Pipeline Market Analysis by Companies, 2024

Injectable Drug Delivery Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Injectable Drug Delivery Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Injectable Drug Delivery Pipeline Market Segments Outlook (2024)

  • Sustained Release Injectable Systems
  • Needleless Systems
  • Liposomal System

Injectable Drug Delivery Pipeline Market Territories Outlook (2024)

  • The US
  • Europe
  • Israel
  • Japan
  • Canada

Injectable Drug Delivery Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE
  • Ninsho
  • TGA
  • UKCA

Scope

This report provides:

  • Extensive coverage of the injectable drug delivery under development.
  • An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of injectable drug delivery and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of injectable drug delivery under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

AbbVie Inc
Activoris Medizintechnik GmbH
Actuated Medical Inc
Acumen Pharmaceuticals Inc
Adalvo Ltd
AdrenaCard, Inc.
AktiVax Inc.
Alexion Pharmaceuticals Inc
Alsensa ApS
AltruMed LLC
Alvotech Swiss AG
AmacaThera Inc
Amneal Pharmaceuticals Inc
Andone Pharmaceuticals Inc
Antares Pharma Inc
ApiJect Systems Corp
Aptissen SA
Aquavit Pharmaceuticals Inc
Artemes Technologies, Inc.
Ascendis Pharma AS
ASCIL Biopharm
Ash Access Technology Inc
ASIS Corp
Auckland Bioengineering Institute
AzureBio SL
Becton Dickinson and Co
Bespak Ltd
Biocorp Production SA
BioCorRx Inc
BioMark Diagnostics Inc
Biorchestra Co Ltd
BioRestorative Therapies Inc
Bioxis Pharmaceuticals
BoneSupport AB
Boston Children's Hospital
Brigham and Women's Hospital
Brixton Biosciences Inc
Burke Pharmaceuticals LLC
Calla Health Foundation
Cambridge Consultants Ltd
Camurus AB
Carmot Therapeutics Inc
Case Western Reserve University
Cathiva LLC
China Medical System Holdings Ltd
Cincinnati Children's Hospital Medical Center
Clearside BioMedical Inc
Corium LLC
Cosette Pharmaceuticals Inc
CrossCoat Medical LLC
Crossject SA
Curer Inc
DALI Medical Devices Ltd.
DelSite, Inc. (Inactive)
DelSiTech Ltd
Department of Biomedical Engineering Columbia University
Diamyd Medical AB
Difinity Solutions
Drexel University
Duke University
Duoject Medical Systems Inc
E3D Elcam Drug Delivery Devices
Ebenroth BV
Ecole Polytechnique Federale de Lausanne
EmboMedics Inc
Embryyo Technologies Pvt Ltd
Emergent BioSolutions Inc
EmulTech BV
EP Global Communications Inc (Inactive)
EpicentRx Inc
Eveon SAS
EyeCool Therapeutics Inc
EyePoint Pharmaceuticals Inc
F. Hoffmann-La Roche Ltd
FHC Inc
FluGen Inc
Fresenius Kabi AG
GeneSYS-ID Inc
Georgia Institute of Technology
Ghent University
Globe Medical Tech Inc (Inactive)
Gynion LLC
Halozyme Therapeutics Inc
Heron Therapeutics Inc
Hillmed Inc
Ichor Medical Systems Inc
Immunovant Inc
Impulse Biomedical
Inovio Pharmaceuticals Inc
IntraGel Therapeutics Ltd
InVivo Therapeutics Corp
iScience Interventional Inc
Johns Hopkins University
LG Chem Ltd
Liposphere Ltd
Love Lifesciences LLC
Luna Labs USA LLC
LyoGo
Mach32 Inc
Mallinckrodt Plc
Medovate Ltd
Mercator MedSystems Inc
Milestone Scientific Inc
Mingche Biotechnology (Suzhou) Co Ltd
Moderna Inc
Monash University
Morimoto Pharma Co Ltd
NanoSyrinx Ltd
Nemera La Verpilliere
Nemera Szczecin Sp. z.o.o.
Nipro Corp
Nordic Group BV
Northwestern University
Nota Laboratories Inc
Novosanis NV
NuvOx Pharma LLC
Ocular Therapeutix Inc
Ohio State University
Old Dominion University
Origin Endoscopy Inc
Osteo Pharma BV
Oval Medical Technologies Ltd
Owen Mumford Ltd
Palette Life Sciences AB
Pennsylvania State University
Pfizer Inc
Pharmosa Biopharm Inc
Pirouette Medical LLC
Prohibix LLC
ProstaLund AB
Purdue Pharma LP
Purdue University
Pykus Therapeutics Inc
QuiO Technologies LLC
Rafa Laboratories Co Ltd
Rebel Medicine Inc
Recon Therapeutics, LLC
Regeneron Pharmaceuticals Inc
Release Therapeutics
Renovos Biologics Ltd
RepliCel Life Sciences Inc
Rescitech Vision Pvt Ltd
RetinaPharma Technologies Inc
Re-Vana Therapeutics Ltd
Roche Pharma AG
Rutgers The State University of New Jersey
SafePush LLC
Sapporo Medical University School of Medicine
Schott AG
scPharmaceuticals Inc
SHL Medical LLC
Singapore Eye Research Institute
Societe Industrielle De Sonceboz SA
Sorrento Therapeutics Inc (Inactive)
Southern Medical University
Southwest Research Institute
Spinal Restoration Inc (Inactive)
Stevanato Group SpA
Subcuject ApS
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SURGE Therapeutics Inc
Takeda Pharmaceutical Co Ltd
Talphera Inc
TCB medical devices
Tempest Therapeutics Inc
Terumo Corp
Teva Pharmaceutical Industries Ltd
Teva Pharmaceuticals USA Inc
The University of Texas at Austin Division of Housing and Food Service
TheraKine Inc (Inactive)
Tionlab Therapeutics
Twin Star Medical Inc
Unilife Corporation
University College London
University of Calgary
University of California San Diego
University of California San Francisco
University of Connecticut Health Center
University of Delaware
University of Dundee
University of Florida
University of Galway
University of Kentucky
University of Liverpool Cancer Research Centre
University of Michigan
University of New Mexico
University of Pittsburgh
University of Saskatchewan
University of South Carolina
University of South Florida
University of Texas at San Antonio
University of Texas Health Science Center at Houston
University of Texas Rio Grande Valley
University of Utah
University of Washington
Vanderbilt University
Vaxxas Pty Ltd
Vera Therapeutics Inc
West Pharmaceutical Services Inc
Windgap Medical Inc
Wuhan Tianshiwei Holdings Co Ltd
Xeris Biopharma Holdings Inc
Ypsomed Holding AG
Zealand Pharma AS
ZebraSci Inc
Zosano Pharma Corp

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Injectable Drug Delivery Overview

3 Products under Development

3.1 Injectable Drug Delivery – Pipeline Products by Stage of Development

3.2 Injectable Drug Delivery – Pipeline Products by Segment

3.3 Injectable Drug Delivery – Pipeline Products by Territory

3.4 Injectable Drug Delivery – Pipeline Products by Regulatory Path

3.5 Injectable Drug Delivery – Pipeline Products by Estimated Approval Date

3.6 Injectable Drug Delivery – Ongoing Clinical Trials

4 Injectable Drug Delivery – Pipeline Products under Development by Companies

4.1 Injectable Drug Delivery Companies – Pipeline Products by Stage of Development

4.2 Injectable Drug Delivery – Pipeline Products by Stage of Development

5 Injectable Drug Delivery Companies and Product Overview

5.1 AbbVie Inc Company Overview

5.1.1 AbbVie Inc Pipeline Products & Ongoing Clinical Trials Overview

5.2 Activoris Medizintechnik GmbH Company Overview

5.2.1 Activoris Medizintechnik GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.3 Actuated Medical Inc Company Overview

5.3.1 Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.4 Acumen Pharmaceuticals Inc Company Overview

5.4.1 Acumen Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.5 Adalvo Ltd Company Overview

5.5.1 Adalvo Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.6 AdrenaCard, Inc. Company Overview

5.6.1 AdrenaCard, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.7 AktiVax Inc. Company Overview

5.7.1 AktiVax Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.8 Alexion Pharmaceuticals Inc Company Overview

5.8.1 Alexion Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.9 Alsensa ApS Company Overview

5.9.1 Alsensa ApS Pipeline Products & Ongoing Clinical Trials Overview

5.10 AltruMed LLC Company Overview

5.10.1 AltruMed LLC Pipeline Products & Ongoing Clinical Trials Overview

5.11 Alvotech Swiss AG Company Overview

5.11.1 Alvotech Swiss AG Pipeline Products & Ongoing Clinical Trials Overview

5.12 AmacaThera Inc Company Overview

5.12.1 AmacaThera Inc Pipeline Products & Ongoing Clinical Trials Overview

5.13 Amneal Pharmaceuticals Inc Company Overview

5.13.1 Amneal Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.14 Andone Pharmaceuticals Inc Company Overview

5.14.1 Andone Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.15 Antares Pharma Inc Company Overview

5.15.1 Antares Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview

5.16 ApiJect Systems Corp Company Overview

5.16.1 ApiJect Systems Corp Pipeline Products & Ongoing Clinical Trials Overview

5.17 Aptissen SA Company Overview

5.17.1 Aptissen SA Pipeline Products & Ongoing Clinical Trials Overview

5.18 Aquavit Pharmaceuticals Inc Company Overview

5.18.1 Aquavit Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.19 Artemes Technologies, Inc. Company Overview

5.19.1 Artemes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.20 Ascendis Pharma AS Company Overview

5.20.1 Ascendis Pharma AS Pipeline Products & Ongoing Clinical Trials Overview

5.21 ASCIL Biopharm Company Overview

5.21.1 ASCIL Biopharm Pipeline Products & Ongoing Clinical Trials Overview

5.22 Ash Access Technology Inc Company Overview

5.22.1 Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview

5.23 ASIS Corp Company Overview

5.23.1 ASIS Corp Pipeline Products & Ongoing Clinical Trials Overview

5.24 Auckland Bioengineering Institute Company Overview

5.24.1 Auckland Bioengineering Institute Pipeline Products & Ongoing Clinical Trials Overview

5.25 AzureBio SL Company Overview

5.25.1 AzureBio SL Pipeline Products & Ongoing Clinical Trials Overview

5.26 Becton Dickinson and Co Company Overview

5.26.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview

5.27 Bespak Ltd Company Overview

5.27.1 Bespak Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.28 Biocorp Production SA Company Overview

5.28.1 Biocorp Production SA Pipeline Products & Ongoing Clinical Trials Overview

5.29 BioCorRx Inc Company Overview

5.29.1 BioCorRx Inc Pipeline Products & Ongoing Clinical Trials Overview

5.30 BioMark Diagnostics Inc Company Overview

5.30.1 BioMark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.31 Biorchestra Co Ltd Company Overview

5.31.1 Biorchestra Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.32 BioRestorative Therapies Inc Company Overview

5.32.1 BioRestorative Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.33 Bioxis Pharmaceuticals Company Overview

5.33.1 Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview

5.34 BoneSupport AB Company Overview

5.34.1 BoneSupport AB Pipeline Products & Ongoing Clinical Trials Overview

5.35 Boston Children’s Hospital Company Overview

5.35.1 Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview

5.36 Brigham and Women’s Hospital Company Overview

5.36.1 Brigham and Women’s Hospital Pipeline Products & Ongoing Clinical Trials Overview

5.37 Brixton Biosciences Inc Company Overview

5.37.1 Brixton Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview

5.38 Burke Pharmaceuticals LLC Company Overview

5.38.1 Burke Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview

5.39 Calla Health Foundation Company Overview

5.39.1 Calla Health Foundation Pipeline Products & Ongoing Clinical Trials Overview

5.40 Cambridge Consultants Ltd Company Overview

5.40.1 Cambridge Consultants Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.41 Camurus AB Company Overview

5.41.1 Camurus AB Pipeline Products & Ongoing Clinical Trials Overview

5.42 Carmot Therapeutics Inc Company Overview

5.42.1 Carmot Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.43 Case Western Reserve University Company Overview

5.43.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview

5.44 Cathiva LLC Company Overview

5.44.1 Cathiva LLC Pipeline Products & Ongoing Clinical Trials Overview

5.45 China Medical System Holdings Ltd Company Overview

5.45.1 China Medical System Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.46 Cincinnati Children’s Hospital Medical Center Company Overview

5.46.1 Cincinnati Children’s Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview

5.47 Clearside BioMedical Inc Company Overview

5.47.1 Clearside BioMedical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.48 Corium LLC Company Overview

5.48.1 Corium LLC Pipeline Products & Ongoing Clinical Trials Overview

5.49 Cosette Pharmaceuticals Inc Company Overview

5.49.1 Cosette Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.50 CrossCoat Medical LLC Company Overview

5.50.1 CrossCoat Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

5.51 Crossject SA Company Overview

5.51.1 Crossject SA Pipeline Products & Ongoing Clinical Trials Overview

5.52 Curer Inc Company Overview

5.52.1 Curer Inc Pipeline Products & Ongoing Clinical Trials Overview

5.53 DALI Medical Devices Ltd. Company Overview

5.53.1 DALI Medical Devices Ltd. Pipeline Products & Ongoing Clinical Trials Overview

5.54 DelSite, Inc. (Inactive) Company Overview

5.54.1 DelSite, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.55 DelSiTech Ltd Company Overview

5.55.1 DelSiTech Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.56 Department of Biomedical Engineering Columbia University Company Overview

5.56.1 Department of Biomedical Engineering Columbia University Pipeline Products & Ongoing Clinical Trials Overview

5.57 Diamyd Medical AB Company Overview

5.57.1 Diamyd Medical AB Pipeline Products & Ongoing Clinical Trials Overview

5.58 Difinity Solutions Company Overview

5.58.1 Difinity Solutions Pipeline Products & Ongoing Clinical Trials Overview

5.59 Drexel University Company Overview

5.59.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview

5.60 Duke University Company Overview

5.60.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview

5.61 Duoject Medical Systems Inc Company Overview

5.61.1 Duoject Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview

5.62 E3D Elcam Drug Delivery Devices Company Overview

5.62.1 E3D Elcam Drug Delivery Devices Pipeline Products & Ongoing Clinical Trials Overview

5.63 Ebenroth BV Company Overview

5.63.1 Ebenroth BV Pipeline Products & Ongoing Clinical Trials Overview

5.64 Ecole Polytechnique Federale de Lausanne Company Overview

5.64.1 Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview

5.65 EmboMedics Inc Company Overview

5.65.1 EmboMedics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.66 Embryyo Technologies Pvt Ltd Company Overview

5.66.1 Embryyo Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.67 Emergent BioSolutions Inc Company Overview

5.67.1 Emergent BioSolutions Inc Pipeline Products & Ongoing Clinical Trials Overview

5.68 EmulTech BV Company Overview

5.68.1 EmulTech BV Pipeline Products & Ongoing Clinical Trials Overview

5.69 EP Global Communications Inc (Inactive) Company Overview

5.69.1 EP Global Communications Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.70 EpicentRx Inc Company Overview

5.70.1 EpicentRx Inc Pipeline Products & Ongoing Clinical Trials Overview

5.71 Eveon SAS Company Overview

5.71.1 Eveon SAS Pipeline Products & Ongoing Clinical Trials Overview

5.72 EyeCool Therapeutics Inc Company Overview

5.72.1 EyeCool Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.73 EyePoint Pharmaceuticals Inc Company Overview

5.73.1 EyePoint Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.74 F. Hoffmann-La Roche Ltd Company Overview

5.74.1 F. Hoffmann-La Roche Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.75 FHC Inc Company Overview

5.75.1 FHC Inc Pipeline Products & Ongoing Clinical Trials Overview

5.76 FluGen Inc Company Overview

5.76.1 FluGen Inc Pipeline Products & Ongoing Clinical Trials Overview

5.77 Fresenius Kabi AG Company Overview

5.77.1 Fresenius Kabi AG Pipeline Products & Ongoing Clinical Trials Overview

5.78 GeneSYS-ID Inc Company Overview

5.78.1 GeneSYS-ID Inc Pipeline Products & Ongoing Clinical Trials Overview

5.79 Georgia Institute of Technology Company Overview

5.79.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview

5.80 Ghent University Company Overview

5.80.1 Ghent University Pipeline Products & Ongoing Clinical Trials Overview

5.81 Globe Medical Tech Inc (Inactive) Company Overview

5.81.1 Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.82 Gynion LLC Company Overview

5.82.1 Gynion LLC Pipeline Products & Ongoing Clinical Trials Overview

5.83 Halozyme Therapeutics Inc Company Overview

5.83.1 Halozyme Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.84 Heron Therapeutics Inc Company Overview

5.84.1 Heron Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.85 Hillmed Inc Company Overview

5.85.1 Hillmed Inc Pipeline Products & Ongoing Clinical Trials Overview

5.86 Ichor Medical Systems Inc Company Overview

5.86.1 Ichor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview

5.87 Immunovant Inc Company Overview

5.87.1 Immunovant Inc Pipeline Products & Ongoing Clinical Trials Overview

5.88 Impulse Biomedical Company Overview

5.88.1 Impulse Biomedical Pipeline Products & Ongoing Clinical Trials Overview

5.89 Inovio Pharmaceuticals Inc Company Overview

5.89.1 Inovio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.90 IntraGel Therapeutics Ltd Company Overview

5.90.1 IntraGel Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.91 InVivo Therapeutics Corp Company Overview

5.91.1 InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview

5.92 iScience Interventional Inc Company Overview

5.92.1 iScience Interventional Inc Pipeline Products & Ongoing Clinical Trials Overview

5.93 Johns Hopkins University Company Overview

5.93.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

5.94 LG Chem Ltd Company Overview

5.94.1 LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.95 Liposphere Ltd Company Overview

5.95.1 Liposphere Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.96 Love Lifesciences LLC Company Overview

5.96.1 Love Lifesciences LLC Pipeline Products & Ongoing Clinical Trials Overview

5.97 Luna Labs USA LLC Company Overview

5.97.1 Luna Labs USA LLC Pipeline Products & Ongoing Clinical Trials Overview

5.98 LyoGo Company Overview

5.98.1 LyoGo Pipeline Products & Ongoing Clinical Trials Overview

5.99 Mach32 Inc Company Overview

5.99.1 Mach32 Inc Pipeline Products & Ongoing Clinical Trials Overview

5.100 Mallinckrodt Plc Company Overview

5.100.1 Mallinckrodt Plc Pipeline Products & Ongoing Clinical Trials Overview

5.101 Medovate Ltd Company Overview

5.101.1 Medovate Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.102 Mercator MedSystems Inc Company Overview

5.102.1 Mercator MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview

5.103 Milestone Scientific Inc Company Overview

5.103.1 Milestone Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview

5.104 Mingche Biotechnology (Suzhou) Co Ltd Company Overview

5.104.1 Mingche Biotechnology (Suzhou) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.105 Moderna Inc Company Overview

5.105.1 Moderna Inc Pipeline Products & Ongoing Clinical Trials Overview

5.106 Monash University Company Overview

5.106.1 Monash University Pipeline Products & Ongoing Clinical Trials Overview

5.107 Morimoto Pharma Co Ltd Company Overview

5.107.1 Morimoto Pharma Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.108 NanoSyrinx Ltd Company Overview

5.108.1 NanoSyrinx Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.109 Nemera La Verpilliere Company Overview

5.109.1 Nemera La Verpilliere Pipeline Products & Ongoing Clinical Trials Overview

5.110 Nemera Szczecin Sp. z.o.o. Company Overview

5.110.1 Nemera Szczecin Sp. z.o.o. Pipeline Products & Ongoing Clinical Trials Overview

5.111 Nipro Corp Company Overview

5.111.1 Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview

5.112 Nordic Group BV Company Overview

5.112.1 Nordic Group BV Pipeline Products & Ongoing Clinical Trials Overview

5.113 Northwestern University Company Overview

5.113.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview

5.114 Nota Laboratories Inc Company Overview

5.114.1 Nota Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview

5.115 Novosanis NV Company Overview

5.115.1 Novosanis NV Pipeline Products & Ongoing Clinical Trials Overview

5.116 NuvOx Pharma LLC Company Overview

5.116.1 NuvOx Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview

5.117 Ocular Therapeutix Inc Company Overview

5.117.1 Ocular Therapeutix Inc Pipeline Products & Ongoing Clinical Trials Overview

5.118 Ohio State University Company Overview

5.118.1 Ohio State University Pipeline Products & Ongoing Clinical Trials Overview

5.119 Old Dominion University Company Overview

5.119.1 Old Dominion University Pipeline Products & Ongoing Clinical Trials Overview

5.120 Origin Endoscopy Inc Company Overview

5.120.1 Origin Endoscopy Inc Pipeline Products & Ongoing Clinical Trials Overview

5.121 Osteo Pharma BV Company Overview

5.121.1 Osteo Pharma BV Pipeline Products & Ongoing Clinical Trials Overview

5.122 Oval Medical Technologies Ltd Company Overview

5.122.1 Oval Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.123 Owen Mumford Ltd Company Overview

5.123.1 Owen Mumford Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.124 Palette Life Sciences AB Company Overview

5.124.1 Palette Life Sciences AB Pipeline Products & Ongoing Clinical Trials Overview

5.125 Pennsylvania State University Company Overview

5.125.1 Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview

5.126 Pfizer Inc Company Overview

5.126.1 Pfizer Inc Pipeline Products & Ongoing Clinical Trials Overview

5.127 Pharmosa Biopharm Inc Company Overview

5.127.1 Pharmosa Biopharm Inc Pipeline Products & Ongoing Clinical Trials Overview

5.128 Pirouette Medical LLC Company Overview

5.128.1 Pirouette Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

5.129 Prohibix LLC Company Overview

5.129.1 Prohibix LLC Pipeline Products & Ongoing Clinical Trials Overview

5.130 ProstaLund AB Company Overview

5.130.1 ProstaLund AB Pipeline Products & Ongoing Clinical Trials Overview

5.131 Purdue Pharma LP Company Overview

5.131.1 Purdue Pharma LP Pipeline Products & Ongoing Clinical Trials Overview

5.132 Purdue University Company Overview

5.132.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview

5.133 Pykus Therapeutics Inc Company Overview

5.133.1 Pykus Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.134 QuiO Technologies LLC Company Overview

5.134.1 QuiO Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview

5.135 Rafa Laboratories Co Ltd Company Overview

5.135.1 Rafa Laboratories Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.136 Rebel Medicine Inc Company Overview

5.136.1 Rebel Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview

5.137 Recon Therapeutics, LLC Company Overview

5.137.1 Recon Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview

5.138 Regeneron Pharmaceuticals Inc Company Overview

5.138.1 Regeneron Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.139 Release Therapeutics Company Overview

5.139.1 Release Therapeutics Pipeline Products & Ongoing Clinical Trials Overview

5.140 Renovos Biologics Ltd Company Overview

5.140.1 Renovos Biologics Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.141 RepliCel Life Sciences Inc Company Overview

5.141.1 RepliCel Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview

5.142 Rescitech Vision Pvt Ltd Company Overview

5.142.1 Rescitech Vision Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.143 RetinaPharma Technologies Inc Company Overview

5.143.1 RetinaPharma Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.144 Re-Vana Therapeutics Ltd Company Overview

5.144.1 Re-Vana Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.145 Roche Pharma AG Company Overview

5.145.1 Roche Pharma AG Pipeline Products & Ongoing Clinical Trials Overview

5.146 Rutgers The State University of New Jersey Company Overview

5.146.1 Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview

5.147 SafePush LLC Company Overview

5.147.1 SafePush LLC Pipeline Products & Ongoing Clinical Trials Overview

5.148 Sapporo Medical University School of Medicine Company Overview

5.148.1 Sapporo Medical University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview

5.149 Schott AG Company Overview

5.149.1 Schott AG Pipeline Products & Ongoing Clinical Trials Overview

5.150 scPharmaceuticals Inc Company Overview

5.150.1 scPharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.151 SHL Medical LLC Company Overview

5.151.1 SHL Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

5.152 Singapore Eye Research Institute Company Overview

5.152.1 Singapore Eye Research Institute Pipeline Products & Ongoing Clinical Trials Overview

5.153 Societe Industrielle De Sonceboz SA Company Overview

5.153.1 Societe Industrielle De Sonceboz SA Pipeline Products & Ongoing Clinical Trials Overview

5.154 Sorrento Therapeutics Inc (Inactive) Company Overview

5.154.1 Sorrento Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.155 Southern Medical University Company Overview

5.155.1 Southern Medical University Pipeline Products & Ongoing Clinical Trials Overview

5.156 Southwest Research Institute Company Overview

5.156.1 Southwest Research Institute Pipeline Products & Ongoing Clinical Trials Overview

5.157 Spinal Restoration Inc (Inactive) Company Overview

5.157.1 Spinal Restoration Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.158 Stevanato Group SpA Company Overview

5.158.1 Stevanato Group SpA Pipeline Products & Ongoing Clinical Trials Overview

5.159 Subcuject ApS Company Overview

5.159.1 Subcuject ApS Pipeline Products & Ongoing Clinical Trials Overview

5.160 Sunshine Guojian Pharmaceutical Shanghai Co Ltd Company Overview

5.160.1 Sunshine Guojian Pharmaceutical Shanghai Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.161 SURGE Therapeutics Inc Company Overview

5.161.1 SURGE Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.162 Takeda Pharmaceutical Co Ltd Company Overview

5.162.1 Takeda Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.163 Talphera Inc Company Overview

5.163.1 Talphera Inc Pipeline Products & Ongoing Clinical Trials Overview

5.164 TCB medical devices Company Overview

5.164.1 TCB medical devices Pipeline Products & Ongoing Clinical Trials Overview

5.165 Tempest Therapeutics Inc Company Overview

5.165.1 Tempest Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.166 Terumo Corp Company Overview

5.166.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview

5.167 Teva Pharmaceutical Industries Ltd Company Overview

5.167.1 Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.168 Teva Pharmaceuticals USA Inc Company Overview

5.168.1 Teva Pharmaceuticals USA Inc Pipeline Products & Ongoing Clinical Trials Overview

5.169 The University of Texas at Austin Division of Housing and Food Service Company Overview

5.169.1 The University of Texas at Austin Division of Housing and Food Service Pipeline Products & Ongoing Clinical Trials Overview

5.170 TheraKine Inc (Inactive) Company Overview

5.170.1 TheraKine Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.171 Tionlab Therapeutics Company Overview

5.171.1 Tionlab Therapeutics Pipeline Products & Ongoing Clinical Trials Overview

5.172 Twin Star Medical Inc Company Overview

5.172.1 Twin Star Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.173 Unilife Corporation Company Overview

5.173.1 Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview

5.174 University College London Company Overview

5.174.1 University College London Pipeline Products & Ongoing Clinical Trials Overview

5.175 University of Calgary Company Overview

5.175.1 University of Calgary Pipeline Products & Ongoing Clinical Trials Overview

5.176 University of California San Diego Company Overview

5.176.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview

5.177 University of California San Francisco Company Overview

5.177.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview

5.178 University of Connecticut Health Center Company Overview

5.178.1 University of Connecticut Health Center Pipeline Products & Ongoing Clinical Trials Overview

5.179 University of Delaware Company Overview

5.179.1 University of Delaware Pipeline Products & Ongoing Clinical Trials Overview

5.180 University of Dundee Company Overview

5.180.1 University of Dundee Pipeline Products & Ongoing Clinical Trials Overview

5.181 University of Florida Company Overview

5.181.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview

5.182 University of Galway Company Overview

5.182.1 University of Galway Pipeline Products & Ongoing Clinical Trials Overview

5.183 University of Kentucky Company Overview

5.183.1 University of Kentucky Pipeline Products & Ongoing Clinical Trials Overview

5.184 University of Liverpool Cancer Research Centre Company Overview

5.184.1 University of Liverpool Cancer Research Centre Pipeline Products & Ongoing Clinical Trials Overview

5.185 University of Michigan Company Overview

5.185.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview

5.186 University of New Mexico Company Overview

5.186.1 University of New Mexico Pipeline Products & Ongoing Clinical Trials Overview

5.187 University of Pittsburgh Company Overview

5.187.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview

5.188 University of Saskatchewan Company Overview

5.188.1 University of Saskatchewan Pipeline Products & Ongoing Clinical Trials Overview

5.189 University of South Carolina Company Overview

5.189.1 University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview

5.190 University of South Florida Company Overview

5.190.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview

5.191 University of Texas at San Antonio Company Overview

5.191.1 University of Texas at San Antonio Pipeline Products & Ongoing Clinical Trials Overview

5.192 University of Texas Health Science Center at Houston Company Overview

5.192.1 University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview

5.193 University of Texas Rio Grande Valley Company Overview

5.193.1 University of Texas Rio Grande Valley Pipeline Products & Ongoing Clinical Trials Overview

5.194 University of Utah Company Overview

5.194.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview

5.195 University of Washington Company Overview

5.195.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview

5.196 Vanderbilt University Company Overview

5.196.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview

5.197 Vaxxas Pty Ltd Company Overview

5.197.1 Vaxxas Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.198 Vera Therapeutics Inc Company Overview

5.198.1 Vera Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.199 West Pharmaceutical Services Inc Company Overview

5.199.1 West Pharmaceutical Services Inc Pipeline Products & Ongoing Clinical Trials Overview

5.200 Windgap Medical Inc Company Overview

5.200.1 Windgap Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.201 Wuhan Tianshiwei Holdings Co Ltd Company Overview

5.201.1 Wuhan Tianshiwei Holdings Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.202 Xeris Biopharma Holdings Inc Company Overview

5.202.1 Xeris Biopharma Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview

5.203 Ypsomed Holding AG Company Overview

5.203.1 Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview

5.204 Zealand Pharma AS Company Overview

5.204.1 Zealand Pharma AS Pipeline Products & Ongoing Clinical Trials Overview

5.205 ZebraSci Inc Company Overview

5.205.1 ZebraSci Inc Pipeline Products & Ongoing Clinical Trials Overview

5.206 Zosano Pharma Corp Company Overview

5.206.1 Zosano Pharma Corp Pipeline Products & Ongoing Clinical Trials Overview

6 Injectable Drug Delivery- Recent Developments

6.1 Oct 30, 2024: United Therapeutics Reports Third Quarter 2024 Financial Results

6.2 Oct 25, 2024: Delcath Systems to Host Third Quarter 2024 Earnings Call

6.3 Oct 17, 2024: Delcath Systems Announces Preliminary Third Quarter 2024 Revenue Results

6.4 Oct 17, 2024: ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024

6.5 Oct 16, 2024: Bespak Announces Closure of North Carolina site

6.6 Oct 10, 2024: West to Host Third-Quarter 2024 Conference Call

6.7 Oct 10, 2024: BD to Announce its Fiscal 2024 Fourth Quarter and Full Year Financial Results

6.8 Oct 07, 2024: BD and TEN23 Health Partner to Advance Efficiency and Quality In Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

6.9 Oct 02, 2024: PharmaJet Names Wouter Latour as Chief Executive Officer

6.10 Oct 01, 2024: Recipharm and Exela Announce Exclusive Strategic Alliance

6.11 Sep 30, 2024: Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results on November 6, 2024

6.12 Aug 30, 2024: Dr. Reddy’s Engages Investors at Upcoming Conferences

6.13 Aug 29, 2024: Anthrax Vaccine Producer Emergent BioSolutions Cutting Nearly 70 Jobs in Lansing

6.14 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.15 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.16 Aug 12, 2024: Raymed Labs: Notice of 32nd Annual General Meeting

6.17 Aug 06, 2024: Halozyme Reports Second Quarter 2024 Financial And Operating Results

6.18 Aug 05, 2024: Delcath Systems Announces Q2 2024 Results and Business Highlights

6.19 Jul 22, 2024: Delcath Systems to Host Second Quarter 2024 Earnings Call

6.20 Jul 17, 2024: ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024

6.21 Jul 03, 2024: BD to Announce Financial Results for its Third Quarter of Fiscal 2024

6.22 Jul 02, 2024: Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 2024

6.23 Jun 13, 2024: Medtronic Confirms Global Layoffs

6.24 May 23, 2024: BioMarin to Lay off 5% of Workforce

6.25 May 14, 2024: BioMarin Pharma Lays Off 170 Workers, Mostly in Bay Area

6.26 May 13, 2024: Novo Nordisk Plans Bond Sale to Fund Expansion

6.27 May 07, 2024: Dr. Reddy’s Laboratories Announces Dividend and Annual General Meeting

6.28 May 02, 2024: Novo Nordisk’s Sales Increased by 22% in Danish kroner and by 24% at Constant Exchange Rates to DKK

65.3 billion in the First Three Months of 2024

6.29 Apr 30, 2024: INCOG BioPharma Services Continues Positive Momentum

6.30 Apr 30, 2024: West to Participate in Upcoming Investor Conference

6.31 Apr 25, 2024: FHI 360 and Partners Introduce Injectable HIV Prevention Method as Part of Research Study

6.32 Apr 19, 2024: Dr. Reddy’s Q4 and FY24 Financial Results Due

6.33 Apr 12, 2024: Biotech Firms Genentech, Sanofi Laying off Hundreds at South San Francisco

6.34 Apr 11, 2024: Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.

6.35 Apr 11, 2024: Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25

6.36 Apr 09, 2024: BioMark to Advance Development of Cancer Treatment for Glioblastoma

6.37 Mar 19, 2024: Delcath Systems to Host Fourth Quarter and Full Year 2023 Results and Business Update Call

6.38 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference

6.39 Mar 12, 2024: Viatris Statement Regarding the Transaction with Insud Pharma

6.40 Mar 05, 20

Table

Injectable Drug Delivery – Pipeline Products by Stage of Development

Injectable Drug Delivery – Pipeline Products by Segment

Injectable Drug Delivery – Pipeline Products by Territory

Injectable Drug Delivery – Pipeline Products by Regulatory Path

Injectable Drug Delivery – Pipeline Products by Estimated Approval Date

Injectable Drug Delivery – Ongoing Clinical Trials

Injectable Drug Delivery Companies – Pipeline Products by Stage of Development

Injectable Drug Delivery – Pipeline Products by Stage of Development

AbbVie Inc Pipeline Products & Ongoing Clinical Trials Overview

NOVADUR Intravitreal Implant – Product Status

NOVADUR Intravitreal Implant – Product Description

Activoris Medizintechnik GmbH Pipeline Products & Ongoing Clinical Trials Overview

opherra Liquid Microdosing Device – Product Status

opherra Liquid Microdosing Device – Product Description

opherra Solid Delivery Device – Product Status

opherra Solid Delivery Device – Product Description

Syrcaject – Product Status

Syrcaject – Product Description

Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

OSII – Product Status

OSII – Product Description

Acumen Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

Intravenous- ACU193 – Product Status

Intravenous- ACU193 – Product Description

Adalvo Ltd Pipeline Products & Ongoing Clinical Trials Overview

Icatibant Pre-Filled Syringe – Product Status

Icatibant Pre-Filled Syringe – Product Description

AdrenaCard, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Adrenacard Auto-Injector – Product Status

Adrenacard Auto-Injector – Product Description

AktiVax Inc. Pipeline Products & Ongoing Clinical Trials Overview

ARAI-2PAM – Product Status

ARAI-2PAM – Product Description

Alexion Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

ALXN1720 Prefilled Syringe – Product Status

ALXN1720 Prefilled Syringe – Product Description

Alexion Pharmaceuticals Inc – Ongoing Clinical Trials Overview

ALXN1720 Prefilled Syringe – A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel, Multicenter Study to Evaluate the Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis

Alsensa ApS Pipeline Products & Ongoing Clinical Trials Overview

SQJCT – Product Status

SQJCT – Product Description

AltruMed LLC Pipeline Products & Ongoing Clinical Trials Overview

DOVE Device – Product Status

DOVE Device – Product Description

Alvotech Swiss AG Pipeline Products & Ongoing Clinical Trials Overview

AVT06 – Eylea – Product Status

AVT06 – Eylea – Product Description

Alvotech Swiss AG – Ongoing Clinical Trials Overview

AVT06 – Eylea – Single-arm, Open Label, Multicenter Clinical Study to Evaluate the Handling and Safety of AVT06 Pre-filled Syringe (PFS) in Subjects With Chorioretinal Vascular Disease Followed by an Optional Extension Phase of AVT06 Pre-filled Syringe (PFS)

AmacaThera Inc Pipeline Products & Ongoing Clinical Trials Overview

AMT-143 – Product Status

AMT-143 – Product Description

AMT-456 – Product Status

AMT-456 – Product Description

AmacaThera Inc – Ongoing Clinical Trials Overview

AMT-143 – A Phase Ib Clinical Study to Assess the Therapeutic Effects of AMT-143

Amneal Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

Dihydroergotamine Autoinjector – Product Status

Dihydroergotamine Autoinjector – Product Description

Prefilled Exenatide Pen Injector – Product Status

Prefilled Exenatide Pen Injector – Product Description

Andone Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

Injectable Delivery Device – Product Status

Injectable Delivery Device – Product Description

Antares Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview

ATRS-1901 Auto-Injector – Product Status

ATRS-1901 Auto-Injector – Product Description

Methotrexate Auto Injector – Ectopic Pregnancy – Product Status

Methotrexate Auto Injector – Ectopic Pregnancy – Product Description

Rescue Pen – Product Status

Rescue Pen – Product Description

Teriparatide Disposable Pen Injector – Product Status

Teriparatide Disposable Pen Injector – Product Description

VAI ATRS-1902 Auto-Injector – Product Status

VAI ATRS-1902 Auto-Injector – Product Description

Vibex QS M Auto-Injector – Product Status

Vibex QS M Auto-Injector – Product Description

ApiJect Systems Corp Pipeline Products & Ongoing Clinical Trials Overview

Prefilled ApiJect Injector – Future Version – Product Status

Prefilled ApiJect Injector – Future Version – Product Description

Prefilled ApiJect Injector – Three-part – Product Status

Prefilled ApiJect Injector – Three-part – Product Description

Prefilled ApiJect Injector – Two-Part – Product Status

Prefilled ApiJect Injector – Two-Part – Product Description

Aptissen SA Pipeline Products & Ongoing Clinical Trials Overview

EVI01 – Product Status

EVI01 – Product Description

TID01 – Product Status

TID01 – Product Description

Aquavit Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

Apollo (PITO-001) – Product Status

Apollo (PITO-001) – Product Description

Artemes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Artemes Magnetic Injection System – Product Status

Artemes Magnetic Injection System – Product Description

Ascendis Pharma AS Pipeline Products & Ongoing Clinical Trials Overview

TransCon CNP Pen Injector – Product Status

TransCon CNP Pen Injector – Product Description

TransCon hGH Pen Injector – Adult – Product Status

TransCon hGH Pen Injector – Adult – Product Description

TransCon hGH Pen Injector – Pediatric – Product Status

TransCon hGH Pen Injector – Pediatric – Product Description

TransCon hGH Pen Injector – Turner Syndrome – Product Status

TransCon hGH Pen Injector – Turner Syndrome – Product Description

TransCon IL-2 ß/Y Pen Injector – Systemic – Product Status

TransCon IL-2 ß/Y Pen Injector – Systemic – Product Description

TransCon PTH Pen Injector – Product Status

TransCon PTH Pen Injector – Product Description

TransCon TLR7/8 Agonist Pen Injector – Intratumoral – Product Status

TransCon TLR7/8 Agonist Pen Injector – Intratumoral – Product Description

ASCIL Biopharm Pipeline Products & Ongoing Clinical Trials Overview

ASTECH – Product Status

ASTECH – Product Description

Combo Connector – Dual Chamber Device – Product Status

Combo Connector – Dual Chamber Device – Product Description

DuoLapse – Product Status

DuoLapse – Product Description

Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview

Zuragen – Product Status

Zuragen – Product Description

ASIS Corp Pipeline Products & Ongoing Clinical Trials Overview

Automatic Subdermal Injection System – Product Status

Automatic Subdermal Injection System – Product Description

Auckland Bioengineering Institute Pipeline Products & Ongoing Clinical Trials Overview

Jet Injection – Product Status

Jet Injection – Product Description

AzureBio SL Pipeline Products & Ongoing Clinical Trials Overview

Injectable Needle – Product Status

Injectable Needle – Product Description

Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview

BD Evolve On-body Injector – Product Status

BD Evolve On-body Injector – Product Description

BD Libertas Wearable Injector – Product Status

BD Libertas Wearable Injector – Product Description

Bespak Ltd Pipeline Products & Ongoing Clinical Trials Overview

INJ200 Autoinjector – Product Status

INJ200 Autoinjector – Product Description

Lila Mix Injector – Product Status

Lila Mix Injector – Product Description

Biocorp Production SA Pipeline Products & Ongoing Clinical Trials Overview

Injay – Product Status

Injay – Product Description

BioCorRx Inc Pipeline Products & Ongoing Clinical Trials Overview

Injectable Naltrexone Implant – BICX101 – Product Status

Injectable Naltrexone Implant – BICX101 – Product Description

Naltrexone Implant – BICX102 – Product Status

Naltrexone Implant – BICX102 – Product Description

Naltrexone Implant – BICX104 – Product Status

Naltrexone Implant – BICX104 – Product Description

BioCorRx Inc – Ongoing Clinical Trials Overview

Naltrexone Implant – BICX102 – Evaluate the Effectiveness of BioCorRx Recovery Program for Alcohol and/or Opioid Use Disorders

BioMark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

Injectable Drug Delivery Device – Product Status

Injectable Drug Delivery Device – Product Description

Biorchestra Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

RNA Drug Delivery System – Product Status

RNA Drug Delivery System – Product Description

BioRestorative Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview

BRTX-100 – Product Status

BRTX-100 – Product Description

Curved Needle Device – Product Status

Curved Needle Device – Product Description

BioRestorative Therapies Inc – Ongoing Clinical Trials Overview

BRTX-100 – A Phase II, Double-blind, Saline-controlled, Randomized Study to Evaluate the Safety and Preliminary Efficacy of a Single Dose Intradiscal Injection of BRTX 100 for Patients with Chronic Lumbar Disc Disease (cLDD)

Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview

Vaccine Delivery Device – Product Status

Vaccine Delivery Device – Product Description

BoneSupport AB Pipeline Products & Ongoing Clinical Trials Overview

Cerament|G – Product Status

Cerament|G – Product Description

BoneSupport AB – Ongoing Clinical Trials Overview

Cerament|G – A Post-Market Prospective Cohort Study on Subjects Receiving CERAMENT G as Part of the Surgical Treatment of Osteomyelitis in a Single-Stage Procedure

Cerament|G – CERAMENT G Device Registry

Cerament|G – Evaluation of the Efficiency of the Bone Substitute Cerament-G Locally Delivering Gentamicin in the Treatment of Chronic Osteomyelitis of Long Bones: Randomized Multicentre Study in the CRIOAc Network – CONVICTION Study

Cerament|G – Post-market Study of Cerament V/G in Foot Osteomyelitis

Cerament|G – Two-stage Treatment of Large Bone Defects with Cerament G and Cerament V plus Auto and/or Allograft Using the Masquelet Technique as Salvage Therapy after Bone Resection in Patients with Septic Pseudarthrosis

Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview

Intravenous Nanoparticle Drug Delivery System – Product Status

Intravenous Nanoparticle Drug Delivery System – Product Description

Brigham and Women’s Hospital Pipeline Products & Ongoing Clinical Trials Overview

I2T2 Device – Product Status

I2T2 Device – Product Description

Brixton Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview

Neural Ice – Product Status

Neural Ice – Product Description

Brixton Biosciences Inc – Ongoing Clinical Trials Overview

Neural Ice – An Open-Label, Non-Randomized Study Investigating the Coolio System (BXT-786 3.0 Device): A Novel Approach for Managing Knee Pain in Osteoarthritis through Cold Energy Regional Analgesic Block

Neural Ice – Injectable Cold Energy Therapy for the Management of Chronic Pain Associated with Osteoarthritis of the Knee: A Multi-center, Randomized, Controlled Study (Ice Study)

Burke Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview

BURKE201 Needle Injection Pen – Product Status

BURKE201 Needle Injection Pen – Product Description

Calla Health Foundation Pipeline Products & Ongoing Clinical Trials Overview

Automated Needle Injector – Product Status

Automated Needle Injector – Product Description

Cambridge Consultants Ltd Pipeline Products & Ongoing Clinical Trials Overview

Flexi-ject – Product Status

Flexi-ject – Product Description

Camurus AB Pipeline Products & Ongoing Clinical Trials Overview

CAM2029 Pre-Filled Syringe – Product Status

CAM2029 Pre-Filled Syringe – Product Description

CAM2032 Pre-Filled Syringe – Product Status

CAM2032 Pre-Filled Syringe – Product Description

CAM2038 Depot Injection – Product Status

CAM2038 Depot Injection – Product Description

CAM2043 Pre-Filled Injection – Product Status

CAM2043 Pre-Filled Injection – Product Description

CAM2047 Pre-Filled Syringe – Product Status

CAM2047 Pre-Filled Syringe – Product Description

Carmot Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

CT-868 Pen Injector – Product Status

CT-868 Pen Injector – Product Description

Carmot Therapeutics Inc – Ongoing Clinical Trials Overview

CT-868 Pen Injector – A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of CT-868 Administered for 16 Weeks to Overweight and Obese Adult Participants with Type 1 Diabetes Mellitus

Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview

Pressure Driven Local Drug Delivery System – Liver Cancer – Product Status

Pressure Driven Local Drug Delivery System – Liver Cancer – Product Description

Cathiva LLC Pipeline Products & Ongoing Clinical Trials Overview

Multi-Needle Injection System – Product Status

Multi-Needle Injection System – Product Description

China Medical System Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview

Methotrexate Injection Pre-filled Syringe – Product Status

Methotrexate Injection Pre-filled Syringe – Product Description

Cincinnati Children’s Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview

Pre-Filled Syringe With Flush – Product Status

Pre-Filled Syringe With Flush – Product Description

Clearside BioMedical Inc Pipeline Products & Ongoing Clinical Trials Overview

SCS Microinjector – Product Status

SCS Microinjector – Product Description

Clearside BioMedical Inc – Ongoing Clinical Trials Overview

SCS Microinjector – A Phase 2, Open-Label, Dose Escalation Trial Assessing the Safety, Tolerability, and Treatment Effect of Bel-sar (AU-011) With Suprachoroidal Administration in Subjects With Choroidal Metastasis From Breast or Lung Primary Tumors

SCS Microinjector – A Phase 2, Randomized, Dose-escalation, Observation-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of RGX-314 Gene Therapy Delivered via a Single Suprachoroidal Space (SCS) Injections in Participants With Diabetic Retinopathy (DR) Without Center Involved-diabetic Macular Edema (CI-DME): ALTITUDE

SCS Microinjector – A Phase 2, Randomized, Dose-escalation, Ranibizumab-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of RGX-314 Gene Therapy Delivered Via One or Two Suprachoroidal Space (SCS) Injections in Participants With Neovascular Age-Related Macular Degeneration (nAMD) (AAVIATE)

SCS Microinjector – A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects with Primary Indeterminate Lesions or Small Choroidal Melanoma

SCS Microinjector – ODYSSEY: A Phase 2b Study of Suprachoroidally Administered CLS-AX in Participants with Neovascular Age-Related Macular Degeneration

Corium LLC Pipeline Products & Ongoing Clinical Trials Overview

MicroJet – Product Status

MicroJet – Product Description

Cosette Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

Vyleesi – Product Status

Vyleesi – Product Description

CrossCoat Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

CCM-D – Product Status

CCM-D – Product Description

Crossject SA Pipeline Products & Ongoing Clinical Trials Overview

ZENEO Hydrocortisone Autoinjector – Product Status

ZENEO Hydrocortisone Autoinjector – Product Description

Curer Inc Pipeline Products & Ongoing Clinical Trials Overview

Injectable Whitlockite-Based Cement – Product Status

Injectable Whitlockite-Based Cement – Product Description

DALI Medical Devices Ltd. Pipeline Products & Ongoing Clinical Trials Overview

SAN-DV – Product Status

SAN-DV – Product Description

SAN-DV Pro – Product Status

SAN-DV Pro – Product Description

SAN-In – Product Status

SAN-In – Product Description

SAN-L – Product Status

SAN-L – Product Description

SAN-P – Product Status

SAN-P – Product Description

Synnect – Product Status

Synnect – Product Description

DelSite, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

GelSure – Product Status

GelSure – Product Description

DelSiTech Ltd Pipeline Products & Ongoing Clinical Trials Overview

DST1308 – Product Status

DST1308 – Product Description

Injectable Depot – HIV Prevention – Product Status

Injectable Depot – HIV Prevention – Product Description

Injectable Depot – Pregnancy Prevention – Product Status

Injectable Depot – Pregnancy Prevention – Product Description

Long-Acting Controlled Release Therapy Device – Ophthalmology – Product Status

Long-Acting Controlled Release Therapy Device – Ophthalmology – Product Description

Department of Biomedical Engineering Columbia University Pipeline Products & Ongoing Clinical Trials Overview

AquaDrive – Product Status

AquaDrive – Product Description

Diamyd Medical AB Pipeline Products & Ongoing Clinical Trials Overview

Nerve Targeting Drug Delivery System – Product Status

Nerve Targeting Drug Delivery System – Product Description

Difinity Solutions Pipeline Products & Ongoing Clinical Trials Overview

NeedSafe – Product Status

NeedSafe – Product Description

Drexel University Pipeline Products & Ongoing Clinical Trials Overview

Injectable Hydrogel – Product Status

Injectable Hydrogel – Product Description

Duke University Pipeline Products & Ongoing Clinical Trials Overview

Flexible Needle Device – Product Status

Flexible Needle Device – Product Description

Flowable Linked Irregular Particle (FLIP) Scaffold – Product Status

Flowable Linked Irregular Particle (FLIP) Scaffold – Product Description

Duoject Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview

Maverick-Emergency Auto-Injector – Product Status

Maverick-Emergency Auto-Injector – Product Description

E3D Elcam Drug Delivery Devices Pipeline Products & Ongoing Clinical Trials Overview

Flexi-Q eMU-C – Product Status

Flexi-Q eMU-C – Product Description

Flexi-Q PFS – Product Status

Flexi-Q PFS – Product Description

Patch Pump (eLVD) – Product Status

Patch Pump (eLVD) – Product Description

Ebenroth BV Pipeline Products & Ongoing Clinical Trials Overview

EpiWatch 1.0 – Product Status

EpiWatch 1.0 – Product Description

EpiWatch 2.0 – Product Status

EpiWatch 2.0 – Product Description

Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview

SPOT-RVC – Product Status

SPOT-RVC – Product Description

EmboMedics Inc Pipeline Products & Ongoing Clinical Trials Overview

Second Generation Injectable Microsphere – Product Status

Second Generation Injectable Microsphere – Product Description

Embryyo Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

Auto-injector – Product Status

Auto-injector – Product Description

Emergent BioSolutions Inc Pipeline Products & Ongoing Clinical Trials Overview

D4 Auto Injector – Product Status

D4 Auto Injector – Product Description

EGRD-001 – Product Status

EGRD-001 – Product Description

Emergard – Product Status

Emergard – Product Description

EmulTech BV Pipeline Products & Ongoing Clinical Trials Overview

IA/IO Injectable Controlled Release PLGA Microsphere – Product Status

IA/IO Injectable Controlled Release PLGA Microsphere – Product Description

IM Injectable Controlled Release PLGA Microsphere – Product Status

IM Injectable Controlled Release PLGA Microsphere – Product Description

IV Injection – Controlled Release PLGA Microsphere – Product Status

IV Injection – Controlled Release PLGA Microsphere – Product Description

EP Global Communications Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

MEMS Trigger Point Needle Device – Product Status

MEMS Trigger Point Needle Device – Product Description

EpicentRx Inc Pipeline Products & Ongoing Clinical Trials Overview

eLoop Administration Device – Product Status

eLoop Administration Device – Product Description

EpicentRx Inc – Ongoing Clinical Trials Overview

eLoop Administration Device – REPLATINUM: A Phase 3, Controlled, Open-label, Global Randomized Study of RRx-001 Administered Sequentially With a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond Small Cell Lung Cancer

Eveon SAS Pipeline Products & Ongoing Clinical Trials Overview

Automated Injection Device – Product Status

Automated Injection Device – Product Description

Injection System – Product Status

Injection System – Product Description

EyeCool Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

ETX-4143 – Product Status

ETX-4143 – Product Description

EyeCool Therapeutics Inc – Ongoing Clinical Trials Overview

ETX-4143 – A Prospective Early-Feasibility Study to Evaluate the Safety and Effectiveness of ETX-4143 2.0 Device in Subjects With Eye Pain

EyePoint Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

Durasert – Front Of Eye Disease – Product Status

Durasert – Front Of Eye Disease – Product Description

Durasert – Knee Osteoarthritis – Product Status

Durasert – Knee Osteoarthritis – Product Description

Durasert – Latanoprost Implant – Product Status

Durasert – Latanoprost Implant – Product Description

EYP-1901 – Anti-VEGF Bioerodible Durasert – Product Status

EYP-1901 – Anti-VEGF Bioerodible Durasert – Product Description

EYP-2301 – Razuprotafib in Durasert E – Product Status

EYP-2301 – Razuprotafib in Durasert E – Product Description

Tethadur System – Product Status

Tethadur System – Product Description

YUTIQ 50 – Product Status

YUTIQ 50 – Product Description

F. Hoffmann-La Roche Ltd Pipeline Products & Ongoing Clinical Trials Overview

Susvimo Port Delivery System (PDS) – Product Status

Susvimo Port Delivery System (PDS) – Product Description

F. Hoffmann-La Roche Ltd – Ongoing Clinical Trials Overview

Susvimo Port Delivery System (PDS) – A Multicenter, Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of the Port Delivery System with Ranibizumab in Patients with Neovascular Age-related Macular Degeneration (Portal)

Susvimo Port Delivery System (PDS) – A Phase III, Multicenter, Randomized, Visual Assessor-Masked, Active Comparator Study Of The Efficacy, Safety, And Pharmacokinetics of The Port Delivery System with Ranibizumab In Chinese Patients with Neovascular Age-Related Macular Degeneration

Susvimo Port Delivery System (PDS) – A Phase IIIb, Global, Multicenter, Randomized, Visual Assessor-Masked Study Of The Efficacy, Safety, And Pharmacokinetics Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab In Patients With Neovascular Age-Related Macular Degeneration (Velodrome)

Susvimo Port Delivery System (PDS) – A Phase IV, Multicenter, Open-Label Study to Assess Corneal Endothelial Cells in Patients With Neovascular Age-Related Macular Degeneration Treated With the Port Delivery System With Ranibizumab (PDS)

FHC Inc Pipeline Products & Ongoing Clinical Trials Overview

Intracerebral Microinjection Instrument – Product Status

Intracerebral Microinjection Instrument – Product Description

FluGen Inc Pipeline Products & Ongoing Clinical Trials Overview

Flugen 101.2 Microneedle-Based Delivery Device – Product Status

Flugen 101.2 Microneedle-Based Delivery Device – Product Description

Microneedle Based Delivery Device – Human Papillomavirus – Product Status

Microneedle Based Delivery Device – Human Papillomavirus – Product Description

Microneedle Delivery Device – Pneumococal – Product Status

Microneedle Delivery Device – Pneumococal – Product Description

Microneedle Delivery Device – Seasonal TIV – Product Status

Microneedle Delivery Device – Seasonal TIV – Product Description

Multivaccine Delivering Microneedle Based Device – Product Status

Multivaccine Delivering Microneedle Based Device – Product Description

Fresenius Kabi AG Pipeline Products & Ongoing Clinical Trials Overview

Pegfilgrastim – Pre-Filled Syringe – Product Status

Pegfilgrastim – Pre-Filled Syringe – Product Description

GeneSYS-ID Inc Pipeline Products & Ongoing Clinical Trials Overview

Rx MyDOSE – Product Status

Rx MyDOSE – Product Description

Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview

Bi-channel Infusion Needle – Product Status

Bi-channel Infusion Needle – Product Description

ePatch – Product Status

ePatch – Product Description

Injection Device – Eye Disease – Product Status

Injection Device – Eye Disease – Product Description

Georgia Institute of Technology – Ongoing Clinical Trials Overview

ePatch – A Randomized Controlled Study to Identify Clinically Actionable Arrhythmia Using the ePatch Extended Wear Holter vs. Standard Wear Holter

ePatch – Develop and Validate Machine-Learning Algorithm to Detect Atrial Fibrillation with Wearable Devices

ePatch – ECG Monitoring Short vs Middle Term After Atrial Fibrillation Ablation

ePatch – Investigation of the Reversibility of Cardiac Conduction Disturbances Following Percutaneous Aortic Valve Implantation in Patients With Severe Aortic Stenosis: The TAVI-Reverse Study

Ghent University Pipeline Products & Ongoing Clinical Trials Overview

Poly-Electrolyte Micropartcle (PEM) System – Product Status

Poly-Electrolyte Micropartcle (PEM) System – Product Description

Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Dual Chamber Safety Prefillable Syringe – Product Status

Dual Chamber Safety Prefillable Syringe – Product Description

Single Chamber Safety Prefillable Syringe – Product Status

Single Chamber Safety Prefillable Syringe – Product Description

Gynion LLC Pipeline Products & Ongoing Clinical Trials Overview

Clarablex – Product Status

Clarablex – Product Description

Halozyme Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

Selatogrel Auto-Injector – Product Status

Selatogrel Auto-Injector – Product Description

Tecentriq SC – Product Status

Tecentriq SC – Product Description

Vyvgart Hytrulo Pre-filled Syringe – Product Status

Vyvgart Hytrulo Pre-filled Syringe – Product Description

Halozyme Therapeutics Inc – Ongoing Clinical Trials Overview

Selatogrel Auto-Injector – Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Self-administered Subcutaneous Selatogrel for Prevention of All-cause Death and Treatment of Acute Myocardial Infarction in Subjects with a Recent History of Acute Myocardial Infarction

Vyvgart Hytrulo Pre-filled Syringe – A Global, Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study to Evaluate the Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC Administered by a Prefilled Syringe in Kidney Transplant Recipients with Antibody-Mediated Rejection

Vyvgart Hytrulo Pre-filled Syringe – A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efgartigimod PH20 SC Administered by Prefilled Syringe in Adult Participants with Thyroid Eye Disease

Vyvgart Hytrulo Pre-filled Syringe – A Randomized, Double-Blinded, Placebo-Controlled, Phase 2, Parallel-Group Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Efgartigimod PH20 SC in Adult Participants with Systemic Sclerosis

Heron Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

ZYNRELEF Prefilled Syringe – Product Status

ZYNRELEF Prefilled Syringe – Product Description

ZYNRELEF Vial Access Needle – Product Status

ZYNRELEF Vial Access Needle – Product Description

Hillmed Inc Pipeline Products & Ongoing Clinical Trials Overview

PelviMap System – Product Status

PelviMap System – Product Description

Hillmed Inc – Ongoing Clinical Trials Overview

PelviMap System – An Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain Management

Ichor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview

TriGrid ID – Product Status

TriGrid ID – Product Description

TriGrid IM – Product Status

TriGrid IM – Product Description

Ichor Medical Systems Inc – Ongoing Clinical Trials Overview

TriGrid IM – A Pilot Study to Assess the Safety and Immunogenicity of a Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients with Newly Diagnosed, Unmethylated Glioblastoma

Immunovant Inc Pipeline Products & Ongoing Clinical Trials Overview

IMVT-1401 – Product Status

IMVT-1401 – Product Description

Impulse Biomedical Pipeline Products & Ongoing Clinical Trials Overview

ZiBiPen – Product Status

ZiBiPen – Product Description

Inovio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

Jupiter Jet – Product Status

Jupiter Jet – Product Description

IntraGel Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview

Gel-Based Drug Delivery System – Colorectal Cancer – Product Status

Gel-Based Drug Delivery System – Colorectal Cancer – Product Description

Gel-Based Drug Delivery System – Female Breast Cancer – Product Status

Gel-Based Drug Delivery System – Female Breast Cancer – Product Description

Gel-Based Drug Delivery System – Ovarian Cancer – Product Status

Gel-Based Drug Delivery System – Ovarian Cancer – Product Description

Gel-Based Drug Delivery System – Prostate Cancer – Product Status

Gel-Based Drug Delivery System – Prostate Cancer – Product Description

Gel-Based Drug Delivery System – Testicular Cancer – Product Status

Gel-Based Drug Delivery System – Testicular Cancer – Product Description

TumoCure Delivery System – Product Status

TumoCure Delivery System – Product Description

TumoG – Product Status

TumoG – Product Description

TumoL – Product Status

TumoL – Product Description

IntraGel Therapeutics Ltd – Ongoing Clinical Trials Overview

TumoCure Delivery System – A Single Arm, Prospective, Open Label, Multi Center, Phase Ib Study to Evaluate the Safety, Tolerability and Initial Efficacy of a Single Intra-tumoral Injection of IntraGel’s Polymer-based Cisplatin-loaded Gel (TumoCure) in Subjects With Progressive or Radio-resistant Primary Head and Neck Tumor

InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview

TrailMaker – Product Status

TrailMaker – Product Description

iScience Interventional Inc Pipeline Products & Ongoing Clinical Trials Overview

iScience Smart Needle – Product Status

iScience Smart Needle – Product Description

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

MPACT-Needle – Product Status

MPACT-Needle – Product Description

LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview

Y-Phasic – Product Status

Y-Phasic – Product Description

Liposphere Ltd Pipeline Products & Ongoing Clinical Trials Overview

AqueousJoint – Product Status

AqueousJoint – Product Description

Liposphere Ltd – Ongoing Clinical Trials Overview

AqueousJoint – Effectiveness and Safety of CCoat Intra-Articular Injections in Mild to Moderate Knee Osteoarthritis: Prospective, Placebo Controlled, Randomized, Double

Figures

Injectable Drug Delivery – Pipeline Products by Stage of Development

Injectable Drug Delivery – Pipeline Products by Segment

Injectable Drug Delivery – Pipeline Products by Territory

Injectable Drug Delivery – Pipeline Products by Regulatory Path

Injectable Drug Delivery – Pipeline Products by Estimated Approval Date

Injectable Drug Delivery – Ongoing Clinical Trials

Frequently asked questions

Injectable Drug Delivery Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Injectable Drug Delivery Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Injectable Drug Delivery Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Injectable Drug Delivery Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.